Mobileye cut to Neutral at UBS as a return to growth is further out

UBS downgraded Mobileye Global (NASDAQ:MBLY) to Neutral with a price target of $14, citing a longer-than-expected return to growth. Challenges include delayed SuperVision system growth and lower unit sales forecasts.